The stock price of Cellebrite DI Ltd (NASDAQ: CLBT) has plunged by -0.18 when compared to previous closing price of 10.91, but the company has seen a -0.18% decline in its stock price over the last five trading sessions. Zacks Investment Research reported 2024-04-10 that Cellebrite DI Ltd. (CLBT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Is It Worth Investing in Cellebrite DI Ltd (NASDAQ: CLBT) Right Now?
Company’s 36-month beta value is 1.53.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CLBT is 61.29M, and currently, short sellers hold a 4.05% ratio of that floaft. The average trading volume of CLBT on April 12, 2024 was 1.00M shares.
CLBT’s Market Performance
CLBT’s stock has seen a -0.18% decrease for the week, with a -5.39% drop in the past month and a 33.95% gain in the past quarter. The volatility ratio for the week is 3.22%, and the volatility levels for the past 30 days are at 3.51% for Cellebrite DI Ltd The simple moving average for the last 20 days is -4.41% for CLBT stock, with a simple moving average of 27.50% for the last 200 days.
Analysts’ Opinion of CLBT
Many brokerage firms have already submitted their reports for CLBT stocks, with Needham repeating the rating for CLBT by listing it as a “Buy.” The predicted price for CLBT in the upcoming period, according to Needham is $13.50 based on the research report published on March 28, 2024 of the current year 2024.
BofA Securities gave a rating of “Buy” to CLBT, setting the target price at $12 in the report published on February 16th of the current year.
CLBT Trading at -0.82% from the 50-Day Moving Average
After a stumble in the market that brought CLBT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -12.88% of loss for the given period.
Volatility was left at 3.51%, however, over the last 30 days, the volatility rate increased by 3.22%, as shares sank -8.33% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +16.35% upper at present.
During the last 5 trading sessions, CLBT fell by -0.18%, which changed the moving average for the period of 200-days by +72.86% in comparison to the 20-day moving average, which settled at $11.34. In addition, Cellebrite DI Ltd saw 25.75% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for CLBT
Current profitability levels for the company are sitting at:
- 0.1 for the present operating margin
- 0.84 for the gross margin
The net margin for Cellebrite DI Ltd stands at -0.25. The total capital return value is set at 0.12. Equity return is now at value -150.08, with -17.09 for asset returns.
Based on Cellebrite DI Ltd (CLBT), the company’s capital structure generated 0.29 points at debt to capital in total, while cash flow to debt ratio is standing at 7.22. The debt to equity ratio resting at 0.41. The interest coverage ratio of the stock is 0.31.
Currently, EBITDA for the company is 43.29 million with net debt to EBITDA at -4.06. When we switch over and look at the enterprise to sales, we see a ratio of 6.34. The receivables turnover for the company is 4.21for trailing twelve months and the total asset turnover is 0.6. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.64.
Conclusion
In a nutshell, Cellebrite DI Ltd (CLBT) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
